Vimarsana
Biggest News Aggregation in the World

Aptamer Sciences Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aptamer Sciences Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aptamer Sciences Inc Today - Breaking & Trending Today

Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201: A Promising Approach to Address Under Medical Needs - Vimarsana News

Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201: A Promising Approach to Address Under Medical Needs

Published: March 26, 2024

/PRNewswire/ -- Aptamer Sciences Inc. (KOSDAQ, 291650) announced the filing of an Investigational New Drug (IND) application for the phase 1 clinical trial of...

Source: prnewswire.com
Related Topics:
Kyonggi DoSouth KoreaHong Jae ChonAprc Aptamer RadioligandNational Cancer CenterAptamer Sciences IncBundang Medical CenterSamsung Medical CenterKorean Ministry Of FoodAptamer SciencesInvestigational New DrugKorean MinistryDrug SafetyAptamer Drug ConjugateEast AsiaNature MedicineMedical CenterSeverance HospitalAptamer Radioligand ConjugateAptamer Immune Stimulator ConjugateDong Il HanSciences IncAptamer Sciences Inc
Aptamers Market to Reach US$ 5.4 Billion by 2027, Impelled by Increasing Usage in Drug Discovery - Vimarsana News

Aptamers Market to Reach US$ 5.4 Billion by 2027, Impelled by Increasing Usage in Drug Discovery

Published: November 16, 2022

Global Aptamers Market Impelled by Increasing Usage in Drug Discovery

Source: einnews.com
Related Topics:
United StatesAptamers Market Companies AnalysisPair Biotechnologies IncVivonics IncSomalogic IncKaneka Eurogentec Sa CorporationTrilink BiotechnologiesAptamer Sciences IncAptamer GroupNeoventures Biotechnology IncAptamers Market SizeAptamers Market ImpelledIncreasing UsageGlobal Industry TrendsKey PlayersMarket Companies AnalysisAptamer SciencesBase Pair BiotechnologiesKaneka CorporationNeoventures BiotechnologyMarket SegmentationMiddle EastExplore Full Report WithMarket PerformanceMarket Outlook
Global Aptamers Market Is Grow at a CAGR of 20.16% and By Type, Technology, Application and Key Players - Vimarsana News

Global Aptamers Market Is Grow at a CAGR of 20.16% and By Type, Technology, Application and Key Players

Published: June 7, 2022

Global Aptamers Market Size, Share, Growth, Segment, Trends, Developing Technologies, Investment Opportunities, Revenue and Forecast to 2028

Source: einnews.com
Related Topics:
United StatesSouth AfricaSaudi ArabiaSouth KoreaSulawesi SelatanGlobal Behavioral Health Care SoftwareBiotechnology EuropeBrowse Summary Of The ResearchDonovan BiotechnologySomalogic IncGovernment Research InstitutesAptamer Sciences IncTherapeutics DevelopmentMarket Research Pvt LtdTeam Market ResearchContract Research OrganizationsVivonics IncA Look At Related Research InsightsMarket ResearchAtdbio LtdBarrick LabPair BiotechnologiesServices MarketAptamer GroupNeoventures Biotechnology Inc
Aptamers Market worth $342 million by 2026 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Aptamers Market worth $342 million by 2026 - Exclusive Report by MarketsandMarkets™

Published: March 4, 2022

Aptamers Market worth $342 million by 2026 – Exclusive Report by MarketsandMarkets™

Source: sandiegosun.com
Related Topics:
United StatesSouth KoreaAsia PacificAashish MehraRaptamer Discovery GroupSomalogic IncResearch NewswireEnd Users Pharmaceutical Biotechnology CompaniesSee CampaignAptamer Sciences IncAptamer Group United KingdomAcademic Government Research InstitutesMarketby Product TypeEnd UsersBiotechnology CompaniesGovernment Research InstitutesNorth AmericaLatin AmericaMiddle EastSample PagesAptamer GroupUnited KingdomAptamer SciencesFinancial ContentExtended Distribution
Aptamers Market worth $342 million by 2026 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Aptamers Market worth $342 million by 2026 - Exclusive Report by MarketsandMarkets™

Published: March 4, 2022

Aptamers Market worth $342 million by 2026 – Exclusive Report by MarketsandMarkets™

Source: texasguardian.com
Related Topics:
United StatesSouth KoreaAsia PacificAashish MehraRaptamer Discovery GroupSomalogic IncResearch NewswireEnd Users Pharmaceutical Biotechnology CompaniesSee CampaignAptamer Sciences IncAptamer Group United KingdomAcademic Government Research InstitutesMarketby Product TypeEnd UsersBiotechnology CompaniesGovernment Research InstitutesNorth AmericaLatin AmericaMiddle EastSample PagesAptamer GroupUnited KingdomAptamer SciencesFinancial ContentExtended Distribution